Advertisement

 

 

Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A.

Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A.
Author Information (click to view)

Movassagh H, Tatari N, Shan L, Koussih L, Alsubait D, Khattabi M, Redhu NS, Roth M, Tamm M, Chakir J, Gounni AS,


Movassagh H, Tatari N, Shan L, Koussih L, Alsubait D, Khattabi M, Redhu NS, Roth M, Tamm M, Chakir J, Gounni AS, (click to view)

Movassagh H, Tatari N, Shan L, Koussih L, Alsubait D, Khattabi M, Redhu NS, Roth M, Tamm M, Chakir J, Gounni AS,

Advertisement

Oncotarget 2016 Oct 25() doi 10.18632/oncotarget.12884
Abstract

Airway smooth muscle (ASM) hyperplasia is a key feature of airway remodeling in development of lung diseases such as asthma. Anomalous proliferation of ASM cells directly contributes to ASM hyperplasia. However, the molecular mechanisms controlling ASM cell proliferation are not completely understood. Semaphorins are versatile regulators of various cellular processes including cell growth and proliferation. The role of semaphorins in ASM cell proliferation has remained to be addressed. Here, we report that semaphorin 3A (Sema3A) receptor, neuropilin 1 (Nrp1), is expressed on human ASM cells (HASMC) isolated from healthy and asthmatic donors and treatment of these cells with exogenous Sema3A inhibits growth factor-induced proliferation. Sema3A inhibitory effect on HASMC proliferation is associated with decreased tyrosine phosphorylation of PDGFR, downregulation of Rac1 activation, STAT3 and GSK-3β phosphorylation. Bronchial sections from severe asthmatics displayed immunoreactivity of Nrp1, suggestive of functional contribution of Sema3A-Nrp1 axis in airway remodeling. Together, our data suggest Sema3A-Nrp1 signaling as a novel regulatory pathway of ASM hyperplasia.

Submit a Comment

Your email address will not be published. Required fields are marked *

14 + 9 =

[ HIDE/SHOW ]